A Word from Leadership on Forward Together in 2026
Infinity Infusion Solutions is navigating 2026 with clarity, momentum, and a firm commitment to strengthening the future of infusion therapy. This year marks a pivotal moment—one where innovation, growth, adaptability, and strategic focus will define our success and the value we deliver to our provider members.
Across IIS, we are advancing initiatives that align with the evolving needs of our industry and the expectations of the patients and communities we serve. A key focus for 2026 is expanding our portfolio through new drug contracts, ensuring our members have access to the therapies their patients depend on. At the same time, we are investing in enhanced technology solutions designed to streamline operations, improve visibility, and support more informed decision-making at every level of care.
The reimbursement landscape continues to shift rapidly, bringing both challenges and opportunities. IIS is taking a proactive, advocacy-driven approach to ensure our provider members are prepared for new reimbursement changes and broader industry pressures that affect access, affordability, and continuity of care. Our commitment is not only to keep our members informed but to position them ahead of the curve—equipped with the resources, insights, and support needed to navigate these changes successfully.
We are beyond grateful for our teams, our partners, and our members who make our mission possible. Together, we are building a stronger, more connected infusion community—one that is ready to lead through change and elevate the standards of care for patients nationwide.
With appreciation,
Tamra Townsend, CEO
Katie Ivy, COO